Cubist Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 90   

Articles published

CBST 66.16 -0.98 (-1.46%)
price chart
Market Movers : Cubist Pharmaceuticals Inc. (NASDAQ:CBST), Honeywell ...
Shares of Cubist Pharmaceuticals Inc. (NASDAQ:CBST) have received a consensus recommendation of �Buy� from the fourteen ratings firms that are presently covering the stock, AnalystRatings.
Cubist Pharmaceuticals: Ripe For Acquisition?
Large-cap pharmaceutical companies that can easily benefit from the acquisition include Pfizer Inc. (PFE), which could absorb Cubist's sales force into its acute-care division. Eli Lilly and Co (LLY) and Johnson & Johnson (JNJ) could also come to the ...
Cubist Pharmaceuticals Lowered to "Underperform" at Zacks (CBST)  Watch List News (press release)
Cubist Battling Superbugs Offers Remedy for J&J: Real M&A  Businessweek
Related articles »  
Cubist Pharmaceuticals Given Average Recommendation of "Buy" by ...
Cubist Pharmaceuticals logo Shares of Cubist Pharmaceuticals (NASDAQ:CBST) have received a consensus recommendation of �Buy� from the fourteen analysts that are covering the company, ARN reports. One investment analyst has rated the stock with a ...
Cubist Pharmaceuticals Larger Than S&P 500 Component PerkinElmer
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Cubist Pharmaceuticals Inc. (Symbol: CBST) was identified as having a larger market cap than the smaller end of the S&P 500, for example PerkinElmer, Inc.
Related articles »  
Cubist Pharmaceuticals' Antibiotic Accepted for EU Review - Analyst Blog
The European Medicines Agency (EMA) accepted Cubist Pharmaceuticals, Inc .'s ( CBST ) Marketing Authorization Application (MAA) for its investigational antibiotic, ceftolozane/tazobactam.
Cubist to Present New Data from Antibiotics Portfolio at 54th Interscience ...  Business Wire (press release)
Related articles »  
Trending Stocks: Symantec Corporation (NASDAQ:SYMC), Cubist ...
The credit rating agency's �BBB-� rating indicates that the company is a moderate default risk. They also issued a negative credit outlook for the company and gave their stock a three star rating.
Morning Buzz : Goldcorp Inc. (NYSE:GG), Cubist Pharmaceuticals Inc. (NASDAQ ...
On AUG 26, Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) announced that it will present new data at the 54thInterscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 5-9 in Washington, D.C.
Morningstar Gives BBB- Credit Rating to Cubist Pharmaceuticals (CBST)
Cubist Pharmaceuticals logo Cubist Pharmaceuticals (NASDAQ:CBST) has been given a �BBB-� credit rating by analysts at Morningstar.
Hot Stock List : The Mosaic Company (NYSE:MOS), Cubist Pharmaceuticals ...
On AUG 26, Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) announced that it will present new data at the 54thInterscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 5-9 in Washington, D.C.
Related articles »  
Cubist Pharmaceuticals SVP Gregory Stea Unloads 38326 Shares (CBST)
Cubist Pharmaceuticals logo Cubist Pharmaceuticals (NASDAQ:CBST) SVP Gregory Stea unloaded 38,326 shares of the company's stock on the open market in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $65.88, ...